Company profile KRYS
After 38 days of this quarter the interest is at 70.0. Based on that we can calculate that during remaining 53 days it will total up to 168.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 159 261.4% QoQ | 155 -2.5% QoQ | 126 -18.7% QoQ |
| 2020 | 148 236.4% YoY 17.5% QoQ | 156 -1.9% YoY 5.4% QoQ | 181 16.8% YoY 16.0% QoQ | 111 -11.9% YoY -38.7% QoQ |
| 2021 | 129 -12.8% YoY 16.2% QoQ | 125 -19.9% YoY -3.1% QoQ | 120 -33.7% YoY -4.0% QoQ | 290 161.3% YoY 141.7% QoQ |
| 2022 | 235 82.2% YoY -19.0% QoQ | 112 -10.4% YoY -52.3% QoQ | 206 71.7% YoY 83.9% QoQ | 183 -36.9% YoY -11.2% QoQ |
| 2023 | 165 -29.8% YoY -9.8% QoQ | 408 264.3% YoY 147.3% QoQ | 259 25.7% YoY -36.5% QoQ | 175 -4.4% YoY -32.4% QoQ |
| 2024 | 70 -57.6% YoY -60.0% QoQ | - | - | - |
The average 5 years interest of Krystal Biotech was 13.68 per week. The last year interest of Krystal Biotech compared to the last 5 years has changed by 39.47%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 79.66%.
There is not enough data for Krystal Biotech Krystal Biotech stock to provide analysis
There is not enough data for Krystal Biotech Krystal Biotech stock to provide correlation calculation
There is not enough data for Krystal Biotech Krystal Biotech stock to provide analysis
After 39 days of this quarter the interest is at 332.0. Based on that we can calculate that during remaining 52 days it will total up to 775.0. biotechnology company expected interest is significantly higher compared to previous quarter (+44.3%) and same quarter last year (+51.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 181 | 308 70.2% QoQ | 187 -39.3% QoQ | 245 31.0% QoQ |
| 2020 | 511 182.3% YoY 108.6% QoQ | 479 55.5% YoY -6.3% QoQ | 349 86.6% YoY -27.1% QoQ | 413 68.6% YoY 18.3% QoQ |
| 2021 | 586 14.7% YoY 41.9% QoQ | 309 -35.5% YoY -47.3% QoQ | 361 3.4% YoY 16.8% QoQ | 303 -26.6% YoY -16.1% QoQ |
| 2022 | 419 -28.5% YoY 38.3% QoQ | 525 69.9% YoY 25.3% QoQ | 403 11.6% YoY -23.2% QoQ | 336 10.9% YoY -16.6% QoQ |
| 2023 | 511 22.0% YoY 52.1% QoQ | 424 -19.2% YoY -17.0% QoQ | 371 -7.9% YoY -12.5% QoQ | 537 59.8% YoY 44.7% QoQ |
| 2024 | 332 -35.0% YoY -38.2% QoQ | - | - | - |
The average 5 years interest of biotechnology company was 31.0 per week. The last year interest of biotechnology company compared to the last 5 years has changed by 20.42%. The interest for biotechnology company is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 80.08%.
After 38 days of this quarter the interest is at 124.0. Based on that we can calculate that during remaining 53 days it will total up to 297.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 41 | 263 541.5% QoQ | 185 -29.7% QoQ | 233 25.9% QoQ |
| 2020 | 199 385.4% YoY -14.6% QoQ | 302 14.8% YoY 51.8% QoQ | 141 -23.8% YoY -53.3% QoQ | 82 -64.8% YoY -41.8% QoQ |
| 2021 | 340 70.9% YoY 314.6% QoQ | 105 -65.2% YoY -69.1% QoQ | 70 -50.4% YoY -33.3% QoQ | 86 4.9% YoY 22.9% QoQ |
| 2022 | 206 -39.4% YoY 139.5% QoQ | 497 373.3% YoY 141.3% QoQ | 214 205.7% YoY -56.9% QoQ | 329 282.6% YoY 53.7% QoQ |
| 2023 | 279 35.4% YoY -15.2% QoQ | 463 -6.8% YoY 65.9% QoQ | 269 25.7% YoY -41.9% QoQ | 394 19.8% YoY 46.5% QoQ |
| 2024 | 124 -55.6% YoY -68.5% QoQ | - | - | - |
The average 5 years interest of genetic medicines was 18.55 per week. The last year interest of genetic medicines compared to the last 5 years has changed by 50.03%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 81.78%.
There is not enough data for beremagene geperpavec to provide analysis
There is not enough data for beremagene geperpavec to provide correlation calculation
There is not enough data for beremagene geperpavec to provide analysis
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. B-VEC expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 199 inf% QoQ | 71 -64.3% QoQ | 333 369.0% QoQ |
| 2020 | 28 inf% YoY -91.6% QoQ | 194 -2.5% YoY 592.9% QoQ | 173 143.7% YoY -10.8% QoQ | 175 -47.4% YoY 1.2% QoQ |
| 2021 | 39 39.3% YoY -77.7% QoQ | 144 -25.8% YoY 269.2% QoQ | 37 -78.6% YoY -74.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 109 179.5% YoY inf% QoQ | 146 1.4% YoY 33.9% QoQ | 207 459.5% YoY 41.8% QoQ | 53 inf% YoY -74.4% QoQ |
| 2023 | 76 -30.3% YoY 43.4% QoQ | 132 -9.6% YoY 73.7% QoQ | 85 -58.9% YoY -35.6% QoQ | 31 -41.5% YoY -63.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of B-VEC was 8.58 per week. The last year interest of B-VEC compared to the last 5 years has changed by -33.45%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -50.78%.
After 38 days of this quarter the interest is at 59.0. Based on that we can calculate that during remaining 53 days it will total up to 141.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 175 | 173 -1.1% QoQ | 201 16.2% QoQ | 151 -24.9% QoQ |
| 2020 | 31 -82.3% YoY -79.5% QoQ | 116 -32.9% YoY 274.2% QoQ | 79 -60.7% YoY -31.9% QoQ | 79 -47.7% YoY 0.0% QoQ |
| 2021 | 61 96.8% YoY -22.8% QoQ | 76 -34.5% YoY 24.6% QoQ | 430 444.3% YoY 465.8% QoQ | 263 232.9% YoY -38.8% QoQ |
| 2022 | 160 162.3% YoY -39.2% QoQ | 287 277.6% YoY 79.4% QoQ | 279 -35.1% YoY -2.8% QoQ | 196 -25.5% YoY -29.7% QoQ |
| 2023 | 151 -5.6% YoY -23.0% QoQ | 262 -8.7% YoY 73.5% QoQ | 217 -22.2% YoY -17.2% QoQ | 178 -9.2% YoY -18.0% QoQ |
| 2024 | 59 -60.9% YoY -66.9% QoQ | - | - | - |
The average 5 years interest of dystrophic epidermolysis bullosa was 13.94 per week. The last year interest of dystrophic epidermolysis bullosa compared to the last 5 years has changed by 12.7%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 12.86%.
There is not enough data for KB105 to provide analysis
There is not enough data for KB105 to provide correlation calculation
There is not enough data for KB105 to provide analysis
There is not enough data for autosomal recessive congenital ichthyosis to provide analysis
There is not enough data for autosomal recessive congenital ichthyosis to provide correlation calculation
There is not enough data for autosomal recessive congenital ichthyosis to provide analysis
There is not enough data for KB104 to provide analysis
There is not enough data for KB104 to provide correlation calculation
There is not enough data for KB104 to provide analysis
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. netherton syndrome expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 47 | 126 168.1% QoQ | 104 -17.5% QoQ | 93 -10.6% QoQ |
| 2020 | 228 385.1% YoY 145.2% QoQ | 137 8.7% YoY -39.9% QoQ | 147 41.3% YoY 7.3% QoQ | 64 -31.2% YoY -56.5% QoQ |
| 2021 | 155 -32.0% YoY 142.2% QoQ | 112 -18.2% YoY -27.7% QoQ | 173 17.7% YoY 54.5% QoQ | 173 170.3% YoY 0.0% QoQ |
| 2022 | 135 -12.9% YoY -22.0% QoQ | 190 69.6% YoY 40.7% QoQ | 273 57.8% YoY 43.7% QoQ | 169 -2.3% YoY -38.1% QoQ |
| 2023 | 171 26.7% YoY 1.2% QoQ | 121 -36.3% YoY -29.2% QoQ | 217 -20.5% YoY 79.3% QoQ | 81 -52.1% YoY -62.7% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of netherton syndrome was 11.22 per week. The last year interest of netherton syndrome compared to the last 5 years has changed by -13.64%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 10.24%.
There is not enough data for KB407 to provide analysis
There is not enough data for KB407 to provide correlation calculation
There is not enough data for KB407 to provide analysis
After 38 days of this quarter the interest is at 140.0. Based on that we can calculate that during remaining 53 days it will total up to 335.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 587 | 608 3.6% QoQ | 480 -21.1% QoQ | 521 8.5% QoQ |
| 2020 | 544 -7.3% YoY 4.4% QoQ | 456 -25.0% YoY -16.2% QoQ | 376 -21.7% YoY -17.5% QoQ | 399 -23.4% YoY 6.1% QoQ |
| 2021 | 424 -22.1% YoY 6.3% QoQ | 384 -15.8% YoY -9.4% QoQ | 411 9.3% YoY 7.0% QoQ | 392 -1.8% YoY -4.6% QoQ |
| 2022 | 459 8.3% YoY 17.1% QoQ | 462 20.3% YoY 0.7% QoQ | 378 -8.0% YoY -18.2% QoQ | 436 11.2% YoY 15.3% QoQ |
| 2023 | 489 6.5% YoY 12.2% QoQ | 420 -9.1% YoY -14.1% QoQ | 347 -8.2% YoY -17.4% QoQ | 450 3.2% YoY 29.7% QoQ |
| 2024 | 140 -71.4% YoY -68.9% QoQ | - | - | - |
The average 5 years interest of Cystic Fibrosis was 35.24 per week. The last year interest of Cystic Fibrosis compared to the last 5 years has changed by -8.54%. The interest for Cystic Fibrosis is seasonal. The last year interest is quite lower compared to 5 years ago. It has decreased by -30.28%.
There is not enough data for KB408 to provide analysis
There is not enough data for KB408 to provide correlation calculation
There is not enough data for KB408 to provide analysis
After 38 days of this quarter the interest is at 140.0. Based on that we can calculate that during remaining 53 days it will total up to 335.0. Alpha-1 antitrypsin deficiency expected interest is significantly lower compared to same quarter last year (-49.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 314 | 447 42.4% QoQ | 549 22.8% QoQ | 304 -44.6% QoQ |
| 2020 | 562 79.0% YoY 84.9% QoQ | 339 -24.2% YoY -39.7% QoQ | 473 -13.8% YoY 39.5% QoQ | 423 39.1% YoY -10.6% QoQ |
| 2021 | 563 0.2% YoY 33.1% QoQ | 485 43.1% YoY -13.9% QoQ | 441 -6.8% YoY -9.1% QoQ | 363 -14.2% YoY -17.7% QoQ |
| 2022 | 687 22.0% YoY 89.3% QoQ | 530 9.3% YoY -22.9% QoQ | 429 -2.7% YoY -19.1% QoQ | 447 23.1% YoY 4.2% QoQ |
| 2023 | 666 -3.1% YoY 49.0% QoQ | 704 32.8% YoY 5.7% QoQ | 636 48.3% YoY -9.7% QoQ | 514 15.0% YoY -19.2% QoQ |
| 2024 | 140 -79.0% YoY -72.8% QoQ | - | - | - |
The average 5 years interest of Alpha-1 antitrypsin deficiency was 38.52 per week. The last year interest of Alpha-1 antitrypsin deficiency compared to the last 5 years has changed by 18.17%. The interest for Alpha-1 antitrypsin deficiency is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 26.23%.
There is not enough data for KB301 to provide analysis
There is not enough data for KB301 to provide correlation calculation
There is not enough data for KB301 to provide analysis
There is not enough data for aesthetic skin conditions to provide analysis
There is not enough data for aesthetic skin conditions to provide correlation calculation
There is not enough data for aesthetic skin conditions to provide analysis
After 34 days of this quarter the interest is at 446.0. Based on that we can calculate that during remaining 58 days it will total up to 1207.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 405 |
| 2019 | 837 106.7% QoQ | 763 -8.8% QoQ | 776 1.7% QoQ | 742 83.2% YoY -4.4% QoQ |
| 2020 | 933 11.5% YoY 25.7% QoQ | 774 1.4% YoY -17.0% QoQ | 858 10.6% YoY 10.9% QoQ | 781 5.3% YoY -9.0% QoQ |
| 2021 | 749 -19.7% YoY -4.1% QoQ | 737 -4.8% YoY -1.6% QoQ | 756 -11.9% YoY 2.6% QoQ | 798 2.2% YoY 5.6% QoQ |
| 2022 | 881 17.6% YoY 10.4% QoQ | 903 22.5% YoY 2.5% QoQ | 884 16.9% YoY -2.1% QoQ | 955 19.7% YoY 8.0% QoQ |
| 2023 | 968 9.9% YoY 1.4% QoQ | 937 3.8% YoY -3.2% QoQ | 988 11.8% YoY 5.4% QoQ | 446 -53.3% YoY -54.9% QoQ |
The average 5 years interest of healthcare industry was 64.89 per week. The last year interest of healthcare industry compared to the last 5 years has changed by 14.99%. The interest for healthcare industry is relatively stable in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 24.76%.
There is not enough data for biotechnology sector. to provide analysis
There is not enough data for biotechnology sector. to provide correlation calculation
There is not enough data for biotechnology sector. to provide analysis